Chugai Pharmaceutical Co., Ltd. Stock OTC Markets
Stocks
CHGCY
US1712691039
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.55 USD | -0.27% |
|
+1.39% | -13.78% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 12,055B 74.16B 65B 60.08B 55.26B 104B 7,151B 106B 718B 282B 3,499B 278B 272B | P/E 2026 * |
23.7x | P/E 2027 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 11,133B 68.49B 60.03B 55.49B 51.03B 96.29B 6,604B 97.83B 663B 260B 3,231B 257B 252B | EV / Sales 2026 * |
8.02x | EV / Sales 2027 * | 7.09x |
| Free-Float |
38.12% | Yield 2026 * |
1.87% | Yield 2027 * | 2.15% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +0.18% | ||
| 1 week | +1.39% | ||
| Current month | -1.86% | ||
| 1 month | -2.62% | ||
| 3 months | -18.93% | ||
| 6 months | -12.21% | ||
| Current year | -13.78% |
| 1 week | 21.66 |  | 23.02 |
| 1 month | 21.51 | | 24.18 |
| Current year | 21.51 | | 34.84 |
| 1 year | 19.5 | | 34.84 |
| 3 years | 13.59 | | 34.84 |
| 5 years | 10.99 | | 34.84 |
| 10 years | 4.49 | | 100 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 2021-02-28 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 2024-03-27 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 2020-02-29 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 2024-03-27 |
| Director/Board Member | 51 | 2025-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.39% | - | - | 74.25B | |
| -2.73% | -1.59% | +52.60% | +150.76% | 1,051B | |
| -1.57% | -3.05% | +52.04% | +48.41% | 609B | |
| -0.41% | +2.11% | +36.99% | +78.09% | 450B | |
| -0.75% | +0.30% | +29.77% | +21.15% | 330B | |
| -1.52% | -1.19% | +34.46% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.99% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.18% | -40.59% | 223B | |
| -0.53% | +1.34% | +23.46% | +56.62% | 198B | |
| -0.72% | +1.69% | +23.40% | +67.14% | 167B | |
| Average | -0.86% | +0.10% | +28.17% | +48.08% | 397.23B | |
| Weighted average by Cap. | -1.13% | -0.58% | +37.15% | +72.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.54B 7.48B 6.92B 6.36B 12B 823B 12.19B 82.68B 32.41B 403B 32.05B 31.35B | 1,535B 9.44B 8.28B 7.65B 7.04B 13.28B 911B 13.49B 91.49B 35.86B 446B 35.46B 34.69B |
| Net income | 509B 3.13B 2.74B 2.54B 2.33B 4.4B 302B 4.47B 30.33B 11.89B 148B 11.76B 11.5B | 593B 3.65B 3.2B 2.95B 2.72B 5.13B 352B 5.21B 35.33B 13.85B 172B 13.69B 13.39B |
| Net Debt | -922B -5.67B -4.97B -4.6B -4.23B -7.97B -547B -8.1B -54.95B -21.54B -268B -21.3B -20.83B | -1,164B -7.16B -6.28B -5.8B -5.34B -10.07B -691B -10.23B -69.37B -27.19B -338B -26.89B -26.3B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | US$22.55 | -0.27% | 348,117 |
| 26-07-17 | US$22.61 | +1.39% | 231,612 |
| 26-07-16 | US$22.30 | +2.20% | 472,916 |
| 26-07-15 | US$21.82 | -2.24% | 261,456 |
| 26-07-14 | US$22.32 | -0.09% | 245,556 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
- CHGCY Stock
Select your edition
All financial news and data tailored to specific country editions
